About A. Woodring
Form D filings for Genomic Life in 2024 list A. Woodring as director.
A. Woodring first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name A. Woodring in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people A. Woodring works with at each company, as listed on that company's latest Form D.
Genomic Life, Inc. · Form D, May 8, 2024
BC
Bradley Cole
Executive officer and director
RS
Randal Scott
Chief Executive Officer and director
KP
Kim Popovits
Director